DE602008003221D1 - Prolinamidderivate als nk3-antagonisten - Google Patents
Prolinamidderivate als nk3-antagonistenInfo
- Publication number
- DE602008003221D1 DE602008003221D1 DE602008003221T DE602008003221T DE602008003221D1 DE 602008003221 D1 DE602008003221 D1 DE 602008003221D1 DE 602008003221 T DE602008003221 T DE 602008003221T DE 602008003221 T DE602008003221 T DE 602008003221T DE 602008003221 D1 DE602008003221 D1 DE 602008003221D1
- Authority
- DE
- Germany
- Prior art keywords
- antagonists
- prolinamide derivatives
- prolinamide
- derivatives
- adhd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07109781 | 2007-06-07 | ||
PCT/EP2008/056589 WO2008148689A1 (en) | 2007-06-07 | 2008-05-29 | Prolinamide derivatives as nk3 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602008003221D1 true DE602008003221D1 (de) | 2010-12-09 |
Family
ID=39639487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602008003221T Active DE602008003221D1 (de) | 2007-06-07 | 2008-05-29 | Prolinamidderivate als nk3-antagonisten |
Country Status (14)
Country | Link |
---|---|
US (1) | US7528136B2 (de) |
EP (1) | EP2155672B1 (de) |
JP (1) | JP2010529069A (de) |
KR (1) | KR101163292B1 (de) |
CN (1) | CN101679241B (de) |
AT (1) | ATE486058T1 (de) |
AU (1) | AU2008258665B2 (de) |
BR (1) | BRPI0812447A2 (de) |
CA (1) | CA2689560A1 (de) |
DE (1) | DE602008003221D1 (de) |
ES (1) | ES2351378T3 (de) |
IL (1) | IL202236A0 (de) |
MX (1) | MX2009013115A (de) |
WO (1) | WO2008148689A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2433940B9 (de) * | 2009-04-28 | 2015-10-28 | Chugai Seiyaku Kabushiki Kaisha | Spiroimidazolonderivat |
US8314250B2 (en) | 2009-11-24 | 2012-11-20 | Hoffmann-La Roche Inc. | Sultam derivatives |
US8618303B2 (en) * | 2011-01-07 | 2013-12-31 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
US9073881B2 (en) | 2011-09-23 | 2015-07-07 | Hoffmann-La Roche Inc. | Benzoic acid derivatives |
KR20140130449A (ko) | 2012-02-24 | 2014-11-10 | 에프. 호프만-라 로슈 아게 | 항바이러스 화합물 |
NO2930176T3 (de) | 2012-12-10 | 2018-07-07 | ||
BR112016003511B8 (pt) | 2014-06-09 | 2023-10-03 | Chugai Pharmaceutical Co Ltd | Composição farmacêutica que contém derivados de hidantoína e uso dos mesmos |
CN105153005A (zh) * | 2015-08-05 | 2015-12-16 | 上海瑞博化学有限公司 | 一种4-羰基-脯氨酸衍生物的制备方法 |
JP7153653B2 (ja) | 2017-02-14 | 2022-10-14 | リサーチ トライアングル インスティテュート | プロリン系神経ペプチドff受容体モジュレーター |
KR102453438B1 (ko) | 2020-06-15 | 2022-10-12 | 주식회사 한중엔시에스 | 리저버 일체형 진공 펌프 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169731A (zh) * | 1994-12-13 | 1998-01-07 | 诺瓦蒂斯有限公司 | 速激肽拮抗剂 |
JO2696B1 (en) * | 2002-12-23 | 2013-03-03 | شركة جانسين فارماسوتيكا ان. في | Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists |
CA2565953A1 (en) * | 2004-05-12 | 2005-11-24 | Pfizer Products Inc. | Piperidine derivatives as nk1 and nk3 antagonists |
-
2008
- 2008-05-29 WO PCT/EP2008/056589 patent/WO2008148689A1/en active Application Filing
- 2008-05-29 MX MX2009013115A patent/MX2009013115A/es active IP Right Grant
- 2008-05-29 EP EP08760181A patent/EP2155672B1/de not_active Not-in-force
- 2008-05-29 AT AT08760181T patent/ATE486058T1/de active
- 2008-05-29 CN CN2008800190899A patent/CN101679241B/zh not_active Expired - Fee Related
- 2008-05-29 DE DE602008003221T patent/DE602008003221D1/de active Active
- 2008-05-29 BR BRPI0812447-7A2A patent/BRPI0812447A2/pt not_active IP Right Cessation
- 2008-05-29 KR KR1020107000221A patent/KR101163292B1/ko not_active IP Right Cessation
- 2008-05-29 AU AU2008258665A patent/AU2008258665B2/en not_active Ceased
- 2008-05-29 ES ES08760181T patent/ES2351378T3/es active Active
- 2008-05-29 CA CA002689560A patent/CA2689560A1/en not_active Abandoned
- 2008-05-29 JP JP2010510747A patent/JP2010529069A/ja active Pending
- 2008-05-30 US US12/129,718 patent/US7528136B2/en not_active Expired - Fee Related
-
2009
- 2009-11-19 IL IL202236A patent/IL202236A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20100028629A (ko) | 2010-03-12 |
IL202236A0 (en) | 2010-06-16 |
KR101163292B1 (ko) | 2012-07-05 |
EP2155672A1 (de) | 2010-02-24 |
BRPI0812447A2 (pt) | 2014-12-02 |
US7528136B2 (en) | 2009-05-05 |
CN101679241A (zh) | 2010-03-24 |
ES2351378T3 (es) | 2011-02-03 |
AU2008258665A1 (en) | 2008-12-11 |
WO2008148689A1 (en) | 2008-12-11 |
CA2689560A1 (en) | 2008-12-11 |
CN101679241B (zh) | 2012-06-27 |
AU2008258665B2 (en) | 2012-07-05 |
JP2010529069A (ja) | 2010-08-26 |
US20080306086A1 (en) | 2008-12-11 |
ATE486058T1 (de) | 2010-11-15 |
MX2009013115A (es) | 2010-01-15 |
EP2155672B1 (de) | 2010-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE486058T1 (de) | Prolinamidderivate als nk3-antagonisten | |
MX2013001614A (es) | Compuestos heterociclico. | |
PE20071152A1 (es) | Compuestos derivados de azabiciclo[3.1.0]hex como moduladores de receptores de dopamina d3 | |
TNSN08372A1 (en) | Heterocyclic amides for use as pharmaceuticals | |
PE20121640A1 (es) | Derivados de pirazina como inhibidores de bace | |
MA32898B1 (fr) | Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone | |
JO2910B1 (en) | Organic compounds | |
ATE438632T1 (de) | Aryl-4-ethinylisoxazolderivate | |
ATE449082T1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor | |
TW200800958A (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
MX2010002899A (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3. | |
MX2011008850A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
ATE466854T1 (de) | 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren | |
MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
ATE512142T1 (de) | Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität | |
CO6270359A2 (es) | Moduladores de piperidinil y piperazinil de y-secretasa | |
PE20141168A1 (es) | Derivados de pirazolidin-3-ona | |
MX2012006293A (es) | Derivados de pirrolidina como antagonista del receptor nk-3. | |
ATE546455T1 (de) | Spiropiperidinderivate als nk3-antagonisten | |
MX2011008178A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
MX2013007411A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
ATE549316T1 (de) | Piperidinderivate als nk3-rezeptorantagonisten | |
ATE498622T1 (de) | Prolinamidtetrazolderivate als nk3- rezeptorantagonisten | |
MX2011007506A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
DE602006007682D1 (de) | 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen |